# LS Investment Group II LLC – FDA Inspection, Oct 30, 2024

Source: https://www.keypedia.com/records/fda_inspections/ls-investment-group-ii-llc/ac1218a2-7f4c-43b9-963c-9a98b204f21e
Source feed: FDA_Inspections

> FDA inspection 1252912 of LS Investment Group II LLC, October 30, 2024. Classification: No Action Indicated (NAI). 4 citations under 21 CFR part 820. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252912
- Company Name: LS Investment Group II LLC
- Inspection Date: 2024-10-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: Cincinnati District Office
- Citation Count: 4

## Related Documents

- FDA Inspection 958102 - 2016-02-05
- [FDA Inspection 858270 - 2013-12-12](https://www.keypedia.com/records/fda_inspections/ls-investment-group-ii-llc/9500c217-2c09-43a9-a93d-6fb80acc4f66)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/laureen-m-geniusz/759a858e-e3f3-4c48-8194-9804c7ab2a7b)

Company: https://www.keypedia.com/companies/ls-investment-group-ii-llc/1796b8a7-cf07-4826-b1d6-f54c9ae74623

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22